Product Images Donepezil Hydrochloride

This is a description of a medication called Donepezil Hydrochloride. It comes in the form of tablets, and the provided code for identification is WoC 62204-120.30.*

This is a description of a medicine called Donepezil Hydrochloride Tablets which has been assigned a registration number of WO 63304-128-30. Other text in the provided data seems to be either numbers or non-relevant characters.*

This appears to be a table showing the mean change in ADAS-cog (a cognitive function test) score from baseline after 3, 6, and 12 weeks of treatment with either Donepezil Hydrochloride at 10mg/day, Donepezil Hydrochloride at 5mg/day or a placebo. However, without access to the full data and context, it is difficult to provide a more specific description.*

This appears to be a table or a chart showing the percentage of patients who have taken either Donepezil Hydrochloride or Placebo and the level of improvement based on the CIBIC-plus rating. The table shows that there were three groups of patients who were administered different treatments: 1) Donepezil Hydrochloride 10mg/day, 2) Donepezil Hydrochloride 5mg/day and 3) Placebo. The rating scale based on patient improvement ranges from Markedly Improved, Moderately Improved, Minimally Improved, No Change, Minimally Worse, Moderately Worse and Markedly Worse.*

This appears to be a graph or chart showing changes in ADAS-cog scores for patients taking different doses of Donopezil Hydrochloride or a placebo. The graph compares a treatment group to a placebo group and shows the cumulative percentage of patients experiencing a certain level of improvement or decline in their scores. Not available.*

This is a medical document that seems to present data on patients who were treated with Donepezil Hydrochloride at doses of 5 and 10 mg/day. The medicine's effectiveness was evaluated based on a CIBIC-plus rating, which is a measure of global function and clinical change. The document also includes a chart that displays the percentage of patients who experienced marked, moderate, minimal, or no improvement or a worsening of their condition.*

This is a description of medication usage. The medication being used is Donepezil Hydrochloride, with a dosage of 10 mg per day. The text also contains information about Placebo, which may be used as an alternative in some cases. The remaining text appears to be a mix of numbers and non-English characters, so it cannot be used to provide further context.*